CSIR-IICT working on new antiviral drugs for COVID-19


The Hyderabad-based CSIR-Indian Institute of Chemical Technology (IICT), which earlier delivered the process to manufacture Favipiravir and Remdesivir drugs for COVID-19 management, has now announced that it is working on new antiviral drugs to tackle COVID-19. CSIR-IICT was one of the first indigenous labs to scour existing antivirals and come up successfully with vital Active Pharma Ingredients (APIs), which were then supplied to Indian companies for making affordable drugs. The Institute is also working on corticosteroids which have become very essential in corona management for moderate and severe patients.


Leave a Reply

Your email address will not be published. Required fields are marked *